Day: April 20, 2021

Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares

SHANGHAI and SAN FRANCISCO, April 20, 2021 (GLOBE NEWSWIRE) — Zai Lab Limited (“Zai Lab” or the “Company”) (NASDAQ:ZLAB, HKEX: 9688), an innovative commercial stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 4,776,000 American depositary shares (“ADSs”), each representing one ordinary share of the Company, at a price of US$150.00 per ADS, and 224,000 ordinary shares, at a price of HK$1164.20 per ordinary share, which will be settled in Hong Kong dollars, based upon each ADS representing one ordinary share and an exchange rate of HK$7.7613 to US$1.00, the spot rate of exchange at the time of pricing. The gross proceeds to Zai Lab from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately US$750 million....

Continue reading

FAT Brands Inc. Announces Completion of $144 Million Whole Business Securitization Transaction

Pricing Significantly Reduces Cost of Capital from the 2020 Securitizations Los Angeles, CA, April 20, 2021 (GLOBE NEWSWIRE) — FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT), a leading global franchising company and parent company of iconic brands including Fatburger, Johnny Rockets, and seven other restaurant concepts, today announced that it has completed an offering of $144,472,000 of Series 2021-1 Fixed Rate Asset-Backed Notes (the “Notes”). This transaction has been structured as a whole business securitization transaction through FAT Brands Royalty I, LLC (“FAT Royalty” or the “Issuer”). The transaction is FAT Brands’ third successful securitization and significantly reduces the cost of capital from the two previously issued 2020 securitizations. The transaction refinances the 2020 bonds and creates significant excess...

Continue reading

Equity Bancshares, Inc. Reports First-Quarter Net Income of $15.1 million and $1.02 Earnings Per Diluted Share

WICHITA, Kan., April 20, 2021 (GLOBE NEWSWIRE) — Equity Bancshares, Inc. (NASDAQ: EQBK), (“Equity”, “the Company”, “we”, “us”, “our”), the Wichita-based holding company of Equity Bank, reported net income of $15.1 million and $1.02 per diluted share, including $0.65 of core earnings per diluted share the first quarter ended March 31, 2021. Core earnings of $0.65 per diluted share for the quarter were driven by non-Paycheck Protection Program (“PPP”) loan growth of $43.7 million, representing growth of 1.9%, or 7.6% annualized growth from December 31, 2020. Further driving results this quarter was the recognition of origination fee income from the successful forgiveness of PPP loans by the SBA; improved operating performance with many of our fee-based initiatives such as wealth management and trust business lines, and debit card...

Continue reading

Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress

Opening of Investigational New Drug Application (IND) with U.S. Food and Drug Administration (FDA) for Phase III study of nomacopan in bullous pemphigoid (BP), a severe dermatological disease with no specific approved treatments Phase III study in severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) is open for enrollment in the U.S. and Europe New data supports potential for nomacopan as a treatment for dry age-related macular degeneration (AMD), a sight-threatening disease with significant unmet need New data shows elevated levels of LTB4 in patients with COVID-19 pneumonia further supporting the potential therapeutic role of nomacopan Cooperative Research and Development Agreement (CRADA) signed with the U.S. Army Institute of Surgical Research (USAISR) for ongoing studies using...

Continue reading

DoubleVerify Announces Pricing of Initial Public Offering

NEW YORK, April 20, 2021 (GLOBE NEWSWIRE) — DoubleVerify Holdings, Inc. (“DoubleVerify”) today announced the pricing of its initial public offering of 13,333,335 shares of common stock at a price to the public of $27.00 per share. DoubleVerify is offering 8,627,452 shares and Providence VII U.S. Holdings L.P. (“Providence”) and other existing stockholders are offering 4,705,883 shares. The shares of common stock are expected to begin trading on the New York Stock Exchange under the ticker symbol “DV” on April 21, 2021. The offering is expected to close on April 23, 2021, subject to the satisfaction of customary closing conditions. The underwriters will have a 30-day option to purchase on a pro rata basis up to an additional 1,350,000 shares from DoubleVerify and up to an additional 650,000 shares from Providence. Goldman Sachs &...

Continue reading

Havertys Announces Timing of First Quarter 2021 Financial Results and Investor Conference Call

ATLANTA, April 20, 2021 (GLOBE NEWSWIRE) — HAVERTYS (NYSE: HVT and HVT.A) will release its first quarter 2021 financial results on Tuesday, April 27, 2021, after the market closes. The company will host a conference call with investors and analysts on Wednesday, April 28, 2021 at 10:00 a.m. (ET) to discuss the results of its operations. Havertys invites interested parties to listen to the live audiocast of the conference call at its website, havertys.com. A replay will be available at the website or via telephone at approximately 1:00 p.m. (ET) through Saturday, May 8, 2021. The number to access the telephone playback is 1-888-203-1112 (access code: 2632821). About HavertysHavertys (NYSE: HVT and HVT.A), established in 1885, is a full-service home furnishings retailer with 121 showrooms in 16 states in the Southern and Midwestern...

Continue reading

Yellow Corporation Bringing New Jobs to Brisbane, California & America

OVERLAND PARK, Kan., April 20, 2021 (GLOBE NEWSWIRE) — Yellow Corporation (NASDAQ: YELL) is recruiting employees for new positions in Brisbane, California. On Monday, April 26 and Tuesday, April 27, Yellow will host two hiring events as the trucking company looks to fill jobs including local drivers, dock workers and box truck drivers. Yellow intends to hire qualified individuals immediately for several jobs in Brisbane with more positions open nationwide. Yellow is the second largest less-than-truckload carrier and the fifth largest transportation company in North America. Yellow’s 30,000 employees are based in all 50 states as well as Puerto Rico, Canada and Mexico. Yellow’s Brisbane hiring events are among more than two dozen similar recruiting events taking place across America between now and July. By the end of 2021, Yellow...

Continue reading

Onex to Announce First-Quarter 2021 Results on May 14, 2021

All amounts in U.S. dollars unless otherwise stated TORONTO, April 20, 2021 (GLOBE NEWSWIRE) — Onex Corporation (TSX: ONEX) will release its results for the first three months ended March 31, 2021 on May 14, 2021. A live broadcast of Onex’ webcast to discuss the results will begin at 11:00 a.m. ET on May 14, 2021. Onex’ Annual Meeting of Shareholders will be held virtually on May 13, 2021 at 10:00 a.m. ET. A link to these webcasts and the on-line replays will be available at www.onex.com/events-and-presentations. About Onex Founded in 1984, Onex manages and invests capital on behalf of its shareholders, institutional investors and high net worth clients from around the world. Onex’ platforms include: Onex Partners, private equity funds focused on mid- to large-cap opportunities in North America and Western Europe; ONCAP, private...

Continue reading

Valneva Switches Focus to Bilateral Discussions to Supply its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

Saint-Herblain (France), April 20, 2021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced it is now focusing on bilateral discussions, on a country by country basis, to supply its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001, and is consequently deprioritizing the ongoing centralized discussions with the European Commission (EC). This follows the recent announcement on April 6, 2021 of positive initial results from the Phase 1/2 clinical trial of VLA20011. Valneva previously announced the advanced stage of its discussions, which started in the third quarter of 2020, with the EC on January 12, 20212. In September 2020, Valneva announced a collaboration with the UK government to provide...

Continue reading

Valneva se tourne vers des discussions bilatérales pour la fourniture de son vaccin inactivé et adjuvanté contre la COVID-19, VLA2001

Saint-Herblain (France), 20 avril 2021 – Valneva SE (“Valneva” ou “le Groupe”), société spécialisée dans les vaccins contre les maladies infectieuses générant d’importants besoins médicaux, a annoncé aujourd’hui qu’elle se focaliserait maintenant sur des discussions bilatérales, pays par pays, pour fournir son candidat vaccin inactivé contre la COVID-19, VLA2001, et, en conséquence, ne donnerait plus la priorité aux discussions de fourniture centralisée actuellement en cours avec la Commission Européenne. Cette annonce fait suite à la publication récente, le 6 avril 2021, de résultats initiaux positifs pour l’étude clinique de Phase 1/2 de VLA20011. Valneva avait annoncé le 12 janvier 2021 être en discussions avancées avec l’Union Européenne2, discussions qui avaient débuté au troisième trimestre 2020. En septembre 2020, Valneva avait...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.